BTK and acute myeloid leukemia: GBD-9 efficiently degraded BTK and GSPT1 proteins with high efficiency (BTK (90%) and GSPT1 (80%) at 50 nM concentration) and inhibited cancer cell growth by recruiting CRBN in a range of DLBCL and AML cell lines.